The Weekly Bioanalysis - An Official Podcast of KCAS
By KCAS
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by KCAS
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 75
Description
"The Weekly Bioanalysis" is a podcast dedicated to discussing Bioanalytical news, tools and services related to the Pharmaceutical, Biopharmaceutical and Biomarker industries. Every month, KCAS will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they've learned about the Bioanalytical world the past couple of weeks.
"The Weekly Bioanalysis" is brought to you by KCAS.KCAS is a progressive growing contract research organization of well over 200 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA and Milan, Italy, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the Pharmaceutical, Biopharmaceutical, Animal Health and Medical Device industries.
| Episode | Date |
|---|---|
|
Rebranding KCAS Bio: Next Steps to an Integrated Future
|
Mar 28, 2024 |
|
Addressing the Needs of Rare Diseases: Challenges & Trends
|
Feb 28, 2024 |
|
The Parallel Evolution of the Bioanalytical Industry and KCAS
|
Jan 28, 2024 |
|
Introduction to Scientific Advisor Team and Recap of 2023
|
Dec 28, 2023 |
|
Drug Development and Where Bioanalytical Fits In
|
Nov 28, 2023 |
|
Looking Forward to the 2023 Autumn Conference Season
|
Sep 28, 2023 |
|
The Evolving World of Antibody-Drug Conjugates and How KCAS Can Help
|
Aug 29, 2023 |
|
Molecular Cell & Gene Therapy, with Special Guest Carrie Vyhlidal, PhD
|
Jun 28, 2023 |
|
Evolution of PK Modalities & the Impact on Regulations
|
Apr 28, 2023 |
|
Recent Advances in Hybrid LC-MS/MS (w/ guests Dawn Dufield and Barry Jones)
|
Mar 24, 2023 |
|
The Role Early Non-clinical Bioanalysis Plays in Your Project
|
Feb 28, 2023 |
|
A Review of 2022's "Fierce 15" and What it Means for 2023
|
Jan 27, 2023 |
|
A Look Back at 2022 While Looking Ahead to 2023 at KCAS
|
Dec 29, 2022 |
|
An Introduction to Active Biomarkers, with Special Guests John Bucksath and Marc Essodaigui
|
Nov 30, 2022 |
|
The 2022 Pharma/Biopharma Trade Show & Conference Season
|
Oct 31, 2022 |
|
Clinical Sample Kitting: Personal Touch Drives Success
|
Sep 30, 2022 |
|
Intro to John Pirro, His New SSA Role, and What's Next for the LBA Team
|
Aug 26, 2022 |
|
The Evolution of Drug Design and Its Impact on Bioanalysis (Part 2)
|
Jul 29, 2022 |
|
The Evolution of Drug Design and Its Impact on Bioanalysis (Part 1)
|
Jun 24, 2022 |
|
Discussing Cell & Gene Therapy Services with Jeff Hester, PhD
|
May 25, 2022 |
|
Building For the Future: New Investments in KCAS
|
Apr 23, 2022 |
|
Renold Capocasale (Vice Chair and Founder of FlowMetric) Joins as Our Guest!
|
Feb 28, 2022 |
|
What Role Can Bioanalysis Play in Your Drug Development Project?
|
Jan 25, 2022 |
|
News and Q&A About the New COVID Variant: OMICRON
|
Dec 23, 2021 |
|
Small Molecules: New Agents Coming for COVID Patients
|
Nov 20, 2021 |
|
Special 50th Episode - LIVE, Together, and "Face-to-Face" for the First Time!!
|
Oct 29, 2021 |
|
Antibody-Drug Conjugates: The Combination of Targeted Delivery + Potent Treatment
|
Oct 26, 2021 |
|
Sonia Hall, PhD (CEO of BioKansas) Joins as Our Guest for Episode 49!
|
Oct 26, 2021 |
|
Official Vaccine Approval! How We Got Here and What It Means Next
|
Sep 03, 2021 |
|
All the News From Around the Pharma and Biopharma Industry, end of Summer of 2021
|
Aug 27, 2021 |
|
The Value of a Dedicated Program Management Team at Your CRO
|
Aug 04, 2021 |
|
Evolving Challenges of COVID with the Emergence of the Delta Variant
|
Jul 27, 2021 |
|
Mainly News Episode: The Latest on Coronavirus and Everything Else Bioanalytical
|
Jul 26, 2021 |
|
The State of Play with Vaccines: The Upcoming and the Next Generations
|
Jun 28, 2021 |
|
The Need for Regulation and Oversight in the Pharma and Biopharma Industries
|
Jun 26, 2021 |
|
Trends in the Pharma Industry (post-COVID) and What It Means for KCAS
|
Jun 26, 2021 |
|
Explaining the Role of Bioanalysis: Questions from a "Beginner"
|
Apr 28, 2021 |
|
State of the Union on Vaccines: Current Status with Descriptions and Comparisons
|
Apr 26, 2021 |
|
What COVID Taught Us About Drug Development Process Limitations
|
Apr 26, 2021 |
|
Trends in Drug Development and the Impact on Consumer Costs
|
Apr 01, 2021 |
|
Changing Strains and the State of Play for Vaccines
|
Feb 18, 2021 |
|
The Top 10 Manufacturers in the Fight Against COVID-19
|
Jan 30, 2021 |
|
A Look Forward at 2021 Drug Development, COVID and Non-COVID
|
Jan 26, 2021 |
|
A 2020 Retrospective: A Look Back on COVID and 2021 Predictions
|
Dec 28, 2020 |
|
mRNA Vaccines: Their Technology, Their History and How They Work
|
Dec 22, 2020 |
|
Our Silver Anniversary Episode! Here's a Highlight On Our Hosts
|
Dec 21, 2020 |
|
Non-GLP, Non-Clinical Discovery Drug Development (Part 3 of 3: From Discovery to Pre-Clinical)
|
Dec 21, 2020 |
|
A Look Back at the 2010 "Fierce 15" - Where Are They Now?
|
Dec 21, 2020 |
|
HERE COME THE VACCINES!! Our BIG 2020 COVID Vaccine and Therapies Round-Up
|
Dec 21, 2020 |
|
A Status Report: The Latest and Greatest on Drug Delivery
|
Dec 21, 2020 |
|
A Business Development Take on the Effects of COVID on Pharma and Biopharma
|
Dec 21, 2020 |
|
What Role Does Bioanalysis Play in the Pharmaceutical and Biopharmaceutical Process? (Part 1 of 4)
|
Dec 21, 2020 |
|
What Role Does Bioanalysis Play in the Pharmaceutical and Biopharmaceutical Process? (Part 2 of 4)
|
Dec 21, 2020 |
|
How an Around-the-Clock CRO Should Continue Work During a Holiday
|
Dec 21, 2020 |
|
What Role Does Bioanalysis Play in the Pharmaceutical and Biopharmaceutical Process? (Part 3 of 4)
|
Dec 21, 2020 |
|
What Role Does Bioanalysis Play in the Pharmaceutical and Biopharmaceutical Process? (Part 4 of 4)
|
Dec 21, 2020 |
|
The Purpose of Validation and How it Gives Confidence in Bioanalytical Data
|
Dec 21, 2020 |
|
The Challenges of Bioanalysis in Non-Routine Matrices
|
Dec 21, 2020 |
|
Reasons for Multiple Trials in Drug Development and GLP (Good Laboratory Practices)
|
Dec 21, 2020 |
|
The Role of Dose Formulation in Bioanalytical Testing
|
Dec 21, 2020 |
|
A Business Review of Drug Development During a Pandemic
|
Dec 21, 2020 |
|
The Impact of COVID on the Drug Development Industry (part 1 of 3)
|
Dec 21, 2020 |
|
The Impact of COVID on the Drug Development Industry (part 2 of 3)
|
Dec 21, 2020 |
|
The Impact of COVID on the Drug Development Industry (part 3 of 3)
|
Dec 21, 2020 |
|
Non-GLP, Non-Clinical Discovery Drug Development (Part 1 of 3: In-Life Services)
|
Dec 21, 2020 |
|
Non-GLP, Non-Clinical Discovery Drug Development (Part 2 of 3: LC/MS-MS and Universal Assays)
|
Dec 21, 2020 |
|
Where Are We w/ COVID Vaccines and Why Do They Take So Long?
|
Dec 21, 2020 |
|
Antibody Testing: Clearing Up Confusion & Misunderstandings
|
Dec 21, 2020 |
|
So What's Been Going On Lately Thats NOT Related to COVID-19?
|
Dec 21, 2020 |
|
What is Bioanalysis? (Part 1 of 3): Small Molecule LC-MS/MS
|
Dec 21, 2020 |
|
What is Bioanalysis? (Part 2 of 3): Large Molecules, Ligand Binding Assays and Biomarkers
|
Dec 21, 2020 |
|
What is Bioanalysis? (Part 3 of 3): Hybrid LC/MS-MS vs Ligand Binding Assays
|
Dec 21, 2020 |
|
Why Not BOTH? Advantages of Having LBA and LC-MS/MS Under One Roof
|
Dec 21, 2020 |
|
Unsung Heroes of Bioanalysis: A Focus on Bioanalytical Support Services
|
Dec 21, 2020 |
|
COVID-19: What in the World Just Happened??
|
Dec 21, 2020 |